Accelerating Delivery of Comprehensive HIV/AIDS/TB services including Prevention, Care, Support and Treatment Adult and Children Living with HIV/AIDS in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief | CDC RFA GH12 121405CONT17

Opportunity Information: Apply for CDC RFA GH12 121405CONT17

This funding opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health, focused on Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR). The project’s central purpose is to accelerate the delivery of comprehensive, integrated HIV/AIDS and tuberculosis (TB) services across the full continuum of care for both adults and children living with HIV in the Republic of Uganda. In practical terms, the opportunity is aimed at strengthening and expanding prevention, clinical care, treatment, and support services in a coordinated way that improves health outcomes and reduces HIV- and TB-related illness and deaths.

The scope described by the title emphasizes a combined HIV/AIDS and TB approach, reflecting the close relationship between the two diseases in high-burden settings. TB remains a leading cause of death among people living with HIV, so programs supported under this kind of award typically prioritize intensified TB case finding among HIV-positive clients, timely TB diagnosis, treatment initiation and completion, infection prevention and control, and preventive therapy where appropriate, alongside strong HIV testing, linkage to care, and antiretroviral therapy (ART) services. The focus on "comprehensive" services also implies attention to the broader package of interventions that support sustained viral suppression and retention in care, such as adherence counseling, patient follow-up, differentiated service delivery models, and addressing barriers that keep clients from consistently accessing treatment.

Because the funding instrument is a cooperative agreement, the CDC is expected to have substantial involvement in the program’s implementation. This generally means the recipient is not operating in isolation; instead, there is active collaboration with CDC technical staff on planning, performance monitoring, quality improvement, and alignment with PEPFAR strategic priorities and reporting requirements. Cooperative agreements frequently involve structured technical guidance, shared decision-making around programmatic adjustments, and close oversight to ensure interventions are evidence-based and consistent with national guidelines and PEPFAR policy.

This opportunity is categorized as continuation funding, which indicates it is intended to extend or continue work that is already underway rather than launch a brand-new initiative from scratch. Continuation awards are commonly used when a program has established systems, implementing partners, service delivery sites, and reporting mechanisms, and the funder wants to maintain momentum while driving further improvements in coverage, quality, and outcomes. The listing also notes that only one award is expected, signaling that the CDC anticipated selecting a single implementing organization or consortium to carry forward a defined portfolio of activities, often across multiple sites or regions, in coordination with the Uganda Ministry of Health and other stakeholders.

The activity category is health, under CFDA number 93.067, which is a CDC global health assistance program area commonly associated with international HIV and related infectious disease work. While the short description provided does not spell out specific targets or geographic coverage, the phrasing "accelerating delivery" suggests an emphasis on scale-up and performance: increasing the number of people who know their HIV status, improving linkage to ART, expanding ART coverage among eligible clients (including children), and improving retention and viral suppression. On the TB side, acceleration commonly means improving screening coverage among people living with HIV, increasing access to diagnostic services, reducing delays to TB treatment, and ensuring strong integration between HIV clinics and TB services.

Eligibility is listed as "Others," with additional clarification referenced in a separate eligibility text field (not included in the excerpt). In many CDC/PEPFAR continuation opportunities, eligible applicants can include established implementing partners such as non-governmental organizations, universities, research institutions, faith-based organizations, or other entities with demonstrated capacity to manage large-scale HIV/TB programs and comply with U.S. government grant requirements. Continuation announcements often prioritize existing recipients or organizations positioned to maintain continuity of services with minimal disruption, especially in clinical programs where interruptions can have serious consequences for patients.

The posting dates indicate the opportunity was created on October 6, 2016, with an original closing date of December 8, 2016. The award ceiling is listed as 0, which typically means the maximum award amount is not specified in the public summary or is determined through other budgeting processes, such as PEPFAR country operational planning and negotiations with the implementing partner. Even when a ceiling is not stated, recipients are generally expected to propose a detailed budget and workplan tied to specific deliverables, staffing plans, monitoring and evaluation activities, and implementation timelines.

Overall, the opportunity is best understood as CDC, under PEPFAR, funding a single continuation partner to push forward integrated HIV/AIDS and TB prevention, care, treatment, and support services for adults and children living with HIV in Uganda, with an emphasis on faster scale-up, stronger quality, and measurable public health impact through close collaboration with CDC.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Accelerating Delivery of Comprehensive HIV/AIDS/TB services including Prevention, Care, Support and Treatment Adult and Children Living with HIV/AIDS in the Republic of Uganda under the President’s Emergency Plan for AIDS Relief" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 06, 2016.
• Applicants must submit their applications by Dec 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH12 121405CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: